Such non-cell autonomous effects could be mediated by Aβ, since deposition of Aβ precedes tau propagation, neuronal depletion, and clinical manifestations of AD by several decades and may thus be an early driver of AD progression (Dubois et al., 2014; Tolar et al., 2021). Here, MAPT is linked to Alzheimer disease.